Publication | Closed Access

Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty

Percutaneous Coronary InterventionCardiovascular DiseaseVascular SurgeryAnticardiolipin AntibodiesCardiologyRisk FactorsVascular BiologyHyperlipidemiaMedicineRelevant RestenosisAtherosclerosisDyslipidemiaCoronary Artery DiseaseAnesthesiology